William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
3M Co. (MMM) to Sell Advanced Ballistic-Protection Business
-
William Blair Downgrades AxoGen, Inc. (AXGN) to Market Perform
-
William Blair Downgrades ShotSpotter (SSTI) to Market Perform
-
William Blair Downgrades Henry Schein (HSIC) to Market Perform
-
William Blair Upgrades Electronic Arts (EA) to Outperform
-
3M to Sell its Advanced Ballistic-Protection Business
-
Allakos Announces Upsizing and Pricing of Public Offering of Common Stock
-
Kinsale Capital Group (KNSL) to Offer 530K Shares of Common Stock
-
Kinsale Capital Group Announces Proposed Public Offering of Common Stock
-
Kinsale Capital Group Announces Proposed Public Offering of Common Stock
-
Beyond Meat® Announces Closing of Public Offering of Common Stock
-
Beyond Meat® Announces Closing of Public Offering of Common Stock
-
Dynatrace Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
Highlander Partners Announces the Formation of Benestar Brands with the Acquisition of Evans Food Group from Wind Point Partners
-
Vapotherm (VAPO) Prices 3.105M Share Offering at $14.50/Sh
-
Vapotherm Announces Pricing of Public Offering of Common Stock
-
Dynatrace Inc. (DT) Prices 35.61M Share IPO at $16/Sh
-
Beyond Meat (BYND) Prices 3.25M Share Common Offering at $160/Sh
-
Beyond Meat® Announces Pricing of Public Offering of Common Stock
-
Beyond Meat® Announces Pricing of Public Offering of Common Stock
-
Dynatrace Announces Pricing of Initial Public Offering
-
CyrusOne Reports Second Quarter 2019 Earnings
-
GHO Capital Announces the Sale of Caprion Biosciences
-
Caprion Biosciences and HistoGeneX Unite Businesses to Create Global Leader in Immune Monitoring and Biomarker Development
-
Vapotherm (VAPO) Announces Proposed Public Offering of Common Stock
-
Vapotherm Announces Proposed Public Offering of Common Stock
-
Amazon Close to Salt Lake City Permit Approval, a Positive for Kornit (KRNT) - William Blair
-
Berry Plastics Group (BERY) to Sell 'Seal for Life Industries' Business to Arsenal Capital Partners for $328M
-
Arsenal Capital Partners Announces Acquisition of Seal for Life Industries
-
Health Catalyst Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Beyond Meat (BYND) Announces 3.25M Share Proposed Public Offering of Common Stock
-
Beyond Meat® Announces Proposed Public Offering of Common Stock
-
Beyond Meat® Announces Proposed Public Offering of Common Stock
-
Health Catalyst (HCAT) IPO Opens 44% Higher
-
William Blair Launches The Active Share Podcast
-
Health Catalyst, Inc. (HCAT) Prices 7M Share IPO at $26/Sh
-
Health Catalyst Announces Pricing of Initial Public Offering
-
PlacementTracker Publishes Q2 2019 PIPE and Private Placement Markets League Tables
-
Audax Private Equity Completes the Sale of Preferred Compounding to HEXPOL
-
William Blair Sees Upside Potential for Yeti Holdings' (YETI) Q2
-
China Automotive Systems (CAAS) Reports Election of Dr. Henry Lu and Dr. Tong Kooi Teo to Board
-
China Automotive Systems Announces Changes to the Board of Directors
-
AssetMark Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares of Common Stock
-
AssetMark Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares of Common Stock
-
Phreesia, Inc. Announces Closing of Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
-
Guggenheim Securities Expands Investment Banking Business in Chicago
-
Guggenheim Securities Expands Investment Banking Business in Chicago
-
Biohaven Pharmaceutical Holding (BHVN) Reiterated Outperform at William Blair Despite CRL
-
William Blair Starts Adeptus Biotechnologies Corp. (ADPT) at Outperform
-
William Blair Starts Change Healthcare Inc. (CHNG) at Outperform

